Xiangyue Zhang

Title: Innovations in Cancer Treatment by Xiangyue Zhang

Introduction

Xiangyue Zhang is an innovative inventor based in Sunnyvale, CA. He has made significant contributions to the field of cancer treatment through his research and patents. His work focuses on the development of methods that utilize inhibitors of erythropoietin receptor activity to combat cancer.

Latest Patents

Xiangyue Zhang holds a patent titled "Method of treating cancer by administering an inhibitor of erythropoietin receptor activity comprising either erythropoietin receptor or erythropoietin protein." This patent provides EPO analogs, anti-EPOR antibodies, anti-EPO antibodies, and fragments that specifically bind to the hetero-EPOR or homo-EPOR or EPO with high affinity. The engineered EPOs and antibodies described in this patent can be utilized to treat patients effectively.

Career Highlights

Throughout his career, Xiangyue Zhang has worked with notable organizations, including Immunedge, Inc. and Leland Stanford Junior University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Xiangyue Zhang has collaborated with esteemed colleagues such as David Kung-Chun Chiu and Edgar George Engleman. These partnerships have further enriched his research and innovation in cancer treatment.

Conclusion

Xiangyue Zhang's work in developing innovative cancer treatment methods showcases his dedication to improving patient outcomes. His contributions to the field are significant and reflect his commitment to advancing medical science.